Stage migration in colorectal cancer related to improved lymph node assessment

被引:32
作者
Derwinger, K. [1 ]
Carlsson, G. [1 ]
Gustavsson, B. [1 ]
机构
[1] Sahlgrens Univ Hosp, Dept Surg, S-41685 Gothenburg, Sweden
来源
EJSO | 2007年 / 33卷 / 07期
关键词
colorectal cancer; lymph node; prognosis; survival; stage migration; multidisciplinary team; oncology; staging;
D O I
10.1016/j.ejso.2007.02.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: The aim of the study was to evaluate the clinical impact of improved cooperation between the treating surgeons and pathologists in a high volume surgical unit. As a measure we used the staging process with special focus on lymph node assessment. Findings: Comparing two periods 5 years apart, we found a significant increase in the number of nodes examined and also an increase in the number of metastasis-positive nodes. Concurrently, we observed a trend in stage migration from stage I/II towards stage III, whilst stage IV remained unchanged. This was one factor that contributed to an increase in the number of patients treated with adjuvant chemotherapy. We also found that the number of assessed nodes had an impact on survival in stage II. The major change in practise was the implementation of a multidisciplinary team conference and the associated possibility of reciprocal feedback. Conclusion: Lymph node status has a key role in cancer staging and in the selection of further therapy. The quality and the standard of the assessment can be improved through multidisciplinary cooperation and it has an impact on the clinical decisions and can affect long-term survival. A correct node status should be mandatory in the evaluation of prognostic factors. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:849 / 853
页数:5
相关论文
共 32 条
  • [1] Adjuvant therapy in stage II colon cancer: Current approaches
    Baddi, L
    Benson, A
    [J]. ONCOLOGIST, 2005, 10 (05) : 325 - 331
  • [2] Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes
    Berger, AC
    Sigurdson, ER
    LeVoyer, T
    Hanlon, A
    Mayer, RJ
    Macdonald, JS
    Catalano, PJ
    Haller, DG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8706 - 8712
  • [3] Bernick P E, 2000, Surg Oncol Clin N Am, V9, P703
  • [4] BERNICK PE, 2000, SURG ONCOL CLIN N AM, V9, P7217
  • [5] Lymph node recovery from colorectal tumor specimens: Recommendation for a minimum number of lymph nodes to be examined
    Cianchi, F
    Palomba, A
    Boddi, V
    Messerini, L
    Pucciani, F
    Perigli, G
    Bechi, P
    Cortesini, C
    [J]. WORLD JOURNAL OF SURGERY, 2002, 26 (03) : 384 - 389
  • [6] Compton CC, 2006, ARCH PATHOL LAB MED, V130, P318
  • [7] Metastatic lymph node size and colorectal cancer prognosis
    Dhar, DK
    Yoshimura, H
    Kinukawa, N
    Maruyama, R
    Tachibana, M
    Kohno, H
    Kubota, H
    Nagasue, N
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2005, 200 (01) : 20 - 28
  • [8] The role of sentinel lymph node mapping in staging of colon and rectal cancer
    Esser, S
    Reilly, WT
    Riley, LB
    Eyvazzadeh, C
    Arcona, S
    [J]. DISEASES OF THE COLON & RECTUM, 2001, 44 (06) : 850 - 854
  • [9] Esser S, 2001, DIS COLON RECTUM, V44, P854, DOI DOI 10.1007/BF02234707
  • [10] Does biomolecular characterization of stage II/III colorectal cancer have any prognostic value?
    Funaioli, Chiara
    Pinto, Carmine
    Mutri, Vita
    Di Fabio, Francesca
    Ceccarelli, Claudio
    Martoni, Andrea Angelo
    [J]. CLINICAL COLORECTAL CANCER, 2006, 6 (01) : 38 - 45